Usha Medi-Soft Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-01-2025
- Paid Up Capital ₹ 1.00 M
as on 15-01-2025
- Company Age 24 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.91 Cr
as on 15-01-2025
About Usha Medi-Soft
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹25.91 Cr.
Yerramreddy Rao and Usharani Yerramreddy serve as directors at the Company.
- CIN/LLPIN
U72200AP2000PTC035596
- Company No.
035596
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Usha Medi-Soft?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yerramreddy Rao  | Director | 03-Nov-2000 | Current |
| Usharani Yerramreddy | Director | 03-Nov-2000 | Current |
Financial Performance of Usha Medi-Soft.
Usha Medi-Soft Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Usha Medi-Soft?
Unlock access to Usha Medi-Soft's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Keerti Bio Medica Private LimitedActive 19 years 2 months
Yerramreddy Rao and Usharani Yerramreddy are mutual person
- Usha Cardiac Centre LimitedActive 30 years 2 months
Yerramreddy Rao and Usharani Yerramreddy are mutual person
Charges (Loans)
₹259.07 M
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 19.00 Cr
- Central Bank Of India : 3.91 Cr
- Vijaya Bank : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Sep 2015 | Syndicate Bank | ₹5.50 Cr | Open |
| 09 Sep 2015 | Syndicate Bank | ₹13.50 Cr | Open |
| 27 Jun 2003 | Vijaya Bank | ₹3.00 Cr | Open |
| 07 Jan 2002 | Central Bank Of India | ₹2.91 Cr | Open |
| 21 Dec 2000 | Central Bank Of India | ₹1.00 Cr | Open |
How Many Employees Work at Usha Medi-Soft?
Unlock and access historical data on people associated with Usha Medi-Soft, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Usha Medi-Soft, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Usha Medi-Soft's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.